New York, May 09, 2016 -- Moody's Investors Service assigned a provisional rating of (P)Baa2 to the proposed senior unsecured note offering of AbbVie Inc. ("AbbVie"). There are no changes to AbbVie's existing ratings, including the Baa1 senior unsecured long term rating and the Prime-2 commercial paper rating. The Baa1 senior unsecured long term rating remains under review for downgrade, and Moody's anticipates a rating outcome of Baa2 with a stable outlook at the conclusion of the rating review. At that time, the rating on the proposed note offering will be converted from (P)Baa2 to Baa2.

Vollständigen Artikel bei Moodys lesen